AI and Pharma Stocks Spark Wall Street Rebound as Intel, Eli Lilly Surge

1 hour ago 1 sources neutral

Key takeaways:

  • AI token rally like FET and RNDR may follow AI infrastructure's equity surge.
  • Resilient risk-on sentiment after geopolitical dip signals bullish short-term crypto momentum.
  • Corning's fiber deal underscores expanding AI buildout, boosting decentralized compute narratives.

Wall Street bounced back on Monday, June 8, 2026, driven by a powerful rally in AI-linked technology shares and blockbuster pharma news. The recovery came after Friday’s sharp selloff triggered by geopolitical worries and weak revenue guidance from key chipmakers.

Intel’s turnaround hopes surged after reports emerged that Alphabet may use Intel’s foundry to manufacture millions of its own AI chips. Intel has long struggled against Nvidia, AMD, and Taiwan Semiconductor, and a deal with Alphabet would mark a major vote of confidence in its comeback effort. The news sent Intel shares sharply higher, fueling speculation that this could be the start of a broader revival for its manufacturing business.

Broadcom and AMD recovered from two sessions of losses, gaining 1.5% and 1.6% respectively, while Nvidia climbed 1.9% and Super Micro Computer jumped 7.7%. Memory stocks also rebounded, with Micron leading the recovery as investors bet on sustained AI data-center demand for high-performance memory. Lam Research, Seagate, and Western Digital were also poised to open higher.

Eli Lilly rose as much as 5% after releasing new data from its ATTAIN-1 and ATTAIN-2 trials. The obesity pill Foundayo showed consistent weight loss across all menopause stages, with women on the highest dose losing 12.8% to 14.4% of body weight over 72 weeks. Up to 83% achieved at least 5% weight loss, and 52% lost 15% or more. The results boost the commercial case for Lilly’s obesity franchise and could support reimbursement talks with insurers.

Nurix Therapeutics surged 38% after a $2.3 billion licensing deal with Roche for its oral BTK degrader bexobrutideg. The non-dilutive funding structure, with a $700 million upfront payment and shared development costs, was met with investor enthusiasm. A Phase 3 trial in chronic lymphocytic leukemia is planned for summer.

Marvell Technology and Flex gained on confirmed S&P 500 inclusion on June 22. Apple edged up 0.3% as its Worldwide Developer Conference kicked off with investors watching for AI updates to Siri and deeper integration across devices. Honeywell slipped 2% after reaffirming full-year guidance and detailing its post-spin-off structure. Corning soared on a multibillion-dollar deal with Amazon tied to data-center fiber and networking demand, showing how the AI buildout is reaching beyond chips into infrastructure.

The session underscored that AI infrastructure remains the dominant market force, with chip stocks, data-center suppliers, and even unexpected names like Corning riding the wave.

Disclaimer

The content on this website is provided for information purposes only and does not constitute investment advice, an offer, or professional consultation. Crypto assets are high-risk and volatile — you may lose all funds. Some materials may include summaries and links to third-party sources; we are not responsible for their content or accuracy. Any decisions you make are at your own risk. Coinalertnews recommends independently verifying information and consulting with a professional before making any financial decisions based on this content.